Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Xinghua Chemistry Co., Ltd. is a prominent Chinese chemical manufacturer that provides critical raw materials and intermediates to the pharmaceutical and biotechnology sectors. The company specializes in the production of guanidine salts, including guanidine nitrate and guanidine hydrochloride, which are widely used as denaturants in protein purification and as intermediates in the synthesis of medicines such as sulfadiazine. Additionally, the company produces basic chemicals like methanol, liquid ammonia, and ammonium nitrate. Headquartered in Shaanxi province and listed on the Shenzhen Stock Exchange (002109), it operates as a subsidiary of the Shaanxi Yanchang Petroleum Group. Its manufacturing capabilities are centered on large-scale chemical synthesis, serving both domestic and international markets in the pharmaceutical, agricultural, and industrial sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Xinghua Chemical.